☆ 4.5 Article

Giant cell myocarditis after first dose of BNT162b2-a case report

EUROPEAN JOURNAL OF HEART FAILURE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Editorial Material Cardiac & Cardiovascular Systems

Biopsy-Proven Giant Cell Myocarditis Following the COVID-19 Vaccine

Kevin Sung et al.

CIRCULATION-HEART FAILURE (2022)

添加到收藏夹

Article Medicine, General & Internal

Fulminant Giant Cell Myocarditis following Heterologous Vaccination of ChAdOx1 nCoV-19 and Pfizer-BioNTech COVID-19

Dong-Hoon Kang et al.

Summary: A female patient developed acute fulminant myocarditis after receiving COVID-19 vaccination and eventually underwent heart transplantation. Autopsy findings suggested a possible link between giant cell myocarditis and vaccination. Clinicians should be aware of the potential development of giant cell myocarditis after COVID-19 vaccination.

MEDICINA-LITHUANIA (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

Carsten Tschoepe et al.

Summary: Inflammatory cardiomyopathy is a disease characterized by inflammatory cell infiltration into the myocardium and is predominantly mediated by viral infection. Despite extensive research, inflammatory cardiomyopathy complicated by left ventricular dysfunction, heart failure or arrhythmia is associated with a poor prognosis. The relative roles of the pathogen, host genomics and environmental factors in disease progression and healing are still under discussion.

NATURE REVIEWS CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

COVID-19-A vascular disease

Hasan K. Siddiqi et al.

Summary: SARS-CoV-2 causes multi-system dysfunction, with emerging evidence indicating that endothelial injury plays a crucial role. Therapies targeting vascular system dysfunction may be important in treating SARS-CoV-2 infection and its long-lasting effects.

TRENDS IN CARDIOVASCULAR MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization

Guy Witberg et al.

Summary: Among 2.5 million patients who received the BNT162b2 mRNA vaccine in a large Israeli health care system, the incidence of myocarditis at 42 days was 2.13 cases per 100,000 persons, with the highest incidence (10.69 per 100,000 persons) among male patients between the ages of 16 and 29 years. Most cases of myocarditis were mild or moderate.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

D. Mevorach et al.

Summary: The incidence of myocarditis increased after receiving the BNT162b2 vaccine in Israel, particularly after the second dose among young male recipients. The clinical presentation of myocarditis after vaccination was usually mild.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Late gadolinium enhancement characteristics in giant cell myocarditis

Shujuan Yang et al.

Summary: The study aimed to demonstrate the characteristics of late gadolinium enhancement (LGE) in patients with giant cell myocarditis (GCM) using cardiovascular magnetic resonance (CMR) imaging. LGE was detected on both ventricular walls in all subjects, with the right-sided septum, subepicardial anterior wall, and subendocardial RV wall being the most common patterns. Extensive LGE, affecting both LV and RV walls, was found to be common in GCM, and subendocardial LGE was frequently presented in GCM, contrary to previous associations with ischemic disease.

ESC HEART FAILURE (2021)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Myocarditis After BNT162b2 and mRNA-1273 Vaccination

Kathryn F. Larson et al.

CIRCULATION (2021)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Myocarditis Temporally Associated With COVID-19 Vaccination

Carolyn M. Rosner et al.

CIRCULATION (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

Julia W. Gargano et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Evaluation of Myocardial Gene Expression Profiling for Superior Diagnosis of Idiopathic Giant-Cell Myocarditis and Clinical Feasibility in a Large Cohort of Patients with Acute Cardiac Decompensation

Felicitas Escher et al.

JOURNAL OF CLINICAL MEDICINE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The Heart in COVID-19 Primary Target or Secondary Bystander?

Peter Libby

JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Incidence, Risk Factors, and Outcome of Life-Threatening Ventricular Arrhythmias in Giant Cell Myocarditis

Kaj Ekstrom et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Improved diagnosis of idiopathic giant cell myocarditis and cardiac sarcoidosis by myocardial gene expression profiling

D. Lassner et al.

EUROPEAN HEART JOURNAL (2014)

添加到收藏夹

Review Medicine, General & Internal

Medical Progress: Myocarditis.

Leslie T. Cooper

NEW ENGLAND JOURNAL OF MEDICINE (2009)

添加到收藏夹

Review Rheumatology

Giant cell myocarditis: Most fatal of autoimmune diseases

ED Rosenstein et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.